glp 1 receptor drugs GLP-1 Agonists and Research to Treat Overeating and Substance Use Disorders How GLP-1 medications are transforming

First-Generation GLP-1 Agonists Meet the Gila monster, a chunky, slow-moving lizard found in the southwestern US and northern Mexico

This is over $540 billion a year if all eligible individuals used itaround 12% of total US healthcare expenditure

Journal of Managed Care & Specialty Pharmacy

Appetite Control: They signal your brain that you are full and slow down your digestion so you stay satisfied longer

Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks

One in eight American adults ( 12%) report having ever used Ozempic or another GLP-1/GIP medications (such as Ozempic, Wegovy, or Mounjaro), including 6% who are currently taking one